Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2022-05-27

Clinical Trial Update: The Impact of an Epidural Anesthetic on the Consumption of Sevoflurane in Major Abdominal Surgery [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial investigating impact of an epidural anesthetic on sevoflurane consumption in major abdominal surgery was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Alberta | Conditions: Bowel Disease, Liver Diseases | Phase 2, Phase 3 | Status: WITHDRAWN